Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Cerilliant
Daiichi Sankyo
Federal Trade Commission
Express Scripts
Cantor Fitzgerald
Chubb
Accenture
Fish and Richardson

Generated: October 23, 2017

DrugPatentWatch Database Preview

MAXALT-MLT Drug Profile

« Back to Dashboard

What is the patent landscape for Maxalt-mlt, and when can generic versions of Maxalt-mlt launch?

Maxalt-mlt is a drug marketed by Merck and is included in one NDA.

The generic ingredient in MAXALT-MLT is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

Summary for Tradename: MAXALT-MLT

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Clinical Trials: see list7
Drug Prices:see details
DailyMed Link:MAXALT-MLT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MAXALT-MLT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998► Subscribe► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for MAXALT-MLT

Drugname Dosage Strength RLD Submissiondate
rizatriptan benzoateOrally Disintegrating Tablets5 mg and 10 mgMaxalt-MLT2/17/2006
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Julphar
Queensland Health
Chubb
Moodys
Deloitte
Baxter
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot